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Cowpox with a severe, generalized eruption was diag-
nosed in an atopic 4-year-old girl by electron microscopy,
virus isolation, polymerase chain reaction, and
immunoglobulin (Ig) M and low-avidity IgG antibodies. The
hemagglutinin gene of the isolate clustered with a Russian
cowpox virus strain, and more distantly, with other cowpox
and vaccinia virus strains. The patient’s dog had
orthopoxvirus-specific antibodies, indicating a possible
transmission route. In Finnish wild rodents, orthopoxvirus
seroprevalences were 0%–92%, in humans the seropreva-
lence was 100% in the age group >50, decreasing towards
younger age groups.
C
owpox is a zoonotic dermatitis affecting, despite its
name, mainly cats and humans. The disease is caused
by cowpox virus, a close relative to vaccinia, smallpox
(variola), and monkeypox viruses within the
Orthopoxvirus genus (1). The relationship between cow-
pox and vaccinia viruses has been unclear since Edward
Jenner used a virus isolate from cows for smallpox vacci-
nation (2,3). Orthopoxviruses, comprising a genus in the
family Poxviridae, are large, brick-shaped viruses with a
200-kbp DNAgenome, and they replicate in the cytoplasm
(4). Because immunity to orthopoxviruses is cross-reac-
tive, smallpox vaccination might have suppressed cowpox
virus infections in the human population. Cowpox virus is
not highly infective for humans and usually produces a
localized lesion mainly on fingers, hands, or face (5). In
immunocompromised persons, however, the disease may
lead to death (6). The virus infects through skin abrasions,
resulting in successive lesions of macular, papular, vesicu-
lar, pustular, ulceral, and eschar stages for 2 weeks.
Systemic symptoms are also common (5). The reservoir
hosts of cowpox are wild rodents (7); wild rodents may
transmit the virus to humans through cats (5) or other pets
that roam outside. Direct transmission from a rodent to a
girl has been recently described (8). Both cowpox and
monkeypox, which was recently transmitted to the United
States by transport of animals indigenous to Africa (9), are
actually orthopoxviruses of their reservoir rodents and are
not well adapted to interhuman spread (1). The misleading
nomenclature is based on the hosts from which they were
first identified (1). Cowpox virus infections have been
detected in Europe and central and northern Asia (1).
Nongeneralized infections in children have been previous-
ly characterized and diagnosed by electron microscopy
(10), virus isolation, polymerase chain reaction (PCR), and
restriction enzyme analysis (10,11).
The Study
A 4-year-old girl from a small farm in eastern Finland
was hospitalized in September 2000 because of umbilicat-
ed vesicopapules, which developed over the previous 5
days (Figure 1), and unresponsiveness to cephalexin. She
had a past history of moderate atopic dermatitis. Animals
at her home farm included a horse, three dogs, and a rab-
bit, but she had no contact with cats because of allergy. On
examination, most lesions were located on her swollen red
extremities, a few were found on the side of her body, and
3-mm lesions were found on the face and vulva. All lesions
were at the same stage of development. She was febrile
with 38°C temperature and feeling unwell. A biopsy sam-
ple from a papule was sent to a virology laboratory, where
orthopoxvirus particles 230 × 300 nm in size were demon-
strated by electron microscopy with negative staining. 
The girl was treated in isolation at the hospital with
chlorhexidine washings and wound dressings with fusidic
acid. Intravenous dicloxacillin was administered to prevent
secondary bacterial infections. On day 12, skin lesions pro-
gressed to deep-seated, hard, black eschars. At the same
time the patient’s general condition improved. Two months
later, all lesions were healed with scars.
A homogenized biopsy sample was used to infect Vero
cells, where a cytopathic effect typical of orthopoxviruses
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Figure 1. Cowpox lesions on patient’s forearm on day 7 after onset
of illness.was seen after 2 days. The isolate, designated
CPXV/FIN/T2000, was shown to contain orthopoxvirus
by electron microscopy, and DNA samples from both the
infected cells and the original biopsy specimen were PCR-
positive for orthopoxvirus thymidine kinase gene (12). The
hemagglutinin (HA) gene of the isolate was amplified
(13), sequenced (948 nucleotides; accession no.
AY366477), and compared to other orthopoxviruses. The
CPXV/FIN/T2000 strain differed 3% to 4% at the
nucleotide level from cowpox virus strains available in
GenBank. The sequences were further subjected to phylo-
genetic analysis: they were aligned by using Clustal X with
Gonnet protein matrix and analyzed by using the maxi-
mum likelihood phylogenetic software TREE-PUZZLE
5.0, applying the Hasegawa model of substitution and per-
forming 25,000 steps. The HA sequence of
CPXV/FIN/T2000 formed a separate clade with cowpox
virus strain GRI-90 (Figure 2), isolated originally from
another 4-year-old girl, who contracted cowpox after play-
ing with a mole near Moscow (14). The reference cowpox
virus strain Brighton grouped with camelpox and variola
viruses instead of other cowpox or vaccinia viruses.
However, because of the high homology of HA genes, this
finding should be interpreted with caution. The remaining
cowpox virus strains clustered together with vaccinia
viruses; this clustering may, in some cases, be explained by
origin from vaccinia virus strains that had escaped to
nature (13). This finding seems not to be the case in
Finland, since the HA nucleotide sequence of vaccinia
virus used in Finland differed 4% both from the strain
CPXV/FIN/T2000 and another Finnish cowpox virus iso-
late from 1989 with an identical HA sequence (data not
shown). Different alignment parameters and the neighbor-
joining method produced the same results with high sup-
port values. Scattered phylogenetic distribution of cowpox
virus strains is supported by data presented by other
researchers and may reflect an ancestral role of cowpox
viruses within the Orthopoxvirus genus; some strains clus-
ter with vaccinia viruses and others (including the refer-
ence Brighton strain) with variola virus (1). 
An immunofluorescence assay (IFA) to measure specif-
ic immunoglobulin (Ig) G, IgM, and avidity of IgG anti-
bodies (15) was established on acetone-fixed,
CPXV/FIN/T2000-strain-infected Vero cells. The patient’s
serum had a high IgM-antibody titer at admission and low
avidity of specific IgG; after 60 days, the IgM level was
low and the IgG avidity high (Table 1).
The serum samples from the patient’s pets were collect-
ed later and tested with IFA. A hunting dog had antibodies
with a titer of 320; another dog had a titer of 20. Thus, a
dog might have transmitted the infection from a wild
rodent to the patient, although cats are thought to be the
main source of human infection (5). 
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Figure 2. Phylogenetic tree of selected orthopoxvirus hemagglu-
tinin genes based on Clustal X alignment and the maximum likeli-
hood method TreePuzzle. Virus sequences used for the analysis
were raccoonpox as an outgroup (GenBank accession no.
M94169); cowpoxvirus strains Brighton Red (AF482758),
FIN/T2000 (AY366477), GRI-90 (Z99047), Hamburg (Z99050),
and Turkmenia (Z99048); vaccinia virus strains IOC (AF229248),
Western Reserve (M93956), and Wyeth (Z99051); variola virus
strains Bangladesh (L22579), Harvey (X65516) and India
(X69198); camelpox virus (AF438165); Cantagalo orthopoxvirus
(AF229247); monkeypox virus (Z99049); and rabbitpox virus
(Z99049).
Table 1. Orthopoxvirus antibodies in sera of the patient and her 
pets
a 
Titer 
Characteristic  IgM  IgG  IgG avidity (%) 
Patient day 7  1280  2560  1.5 
Patient day 14  640  2560  3.1 
Patient day 60  10  640  25 
Old-immunity controls (>50 y)  <10  80–640  50–100 
Negative controls  <10  <10  — 
Dog A  —  <20  — 
Dog B  —  320  50 
Dog C  —  20  50 
Horse  —  <20  — 
Rabbit  —  <20  — 
aIg, immunoglobulin. We further studied orthopoxvirus antibodies by IFA in
Finnish fauna and humans. The seroprevalence rates for
cats and horses were 3.9% and 1.6%, respectively; the
rates for wild rodents (when either serum or lung or heart
extracts was used) were 0% to 92%, depending on the trap-
ping time and the location (Table 2). In Värtsilä, a rural dis-
trict in eastern Finland near where the patient lives, anti-
bodies were found in 1 (2.8%) of 36 rodents. However,
variation of seroprevalence rates in rodents is also influ-
enced by population dynamics: low prevalences are often
found in the increase phase and high prevalences in the
peak phase of rodent population fluctuations. The positive
rodents were mainly bank voles (Clethrionomys glareolus).
The two seropositive horses were from a region near where
the patient lives in eastern Finland, and the three seroposi-
tive cats were free-roaming and found in southern Finland.
In addition, seroprevalence rates of 50% (7/14) and 1.4%
(1/73) have been found in foxes and lynxes, respectively,
from a limited geographic area in Finland (16). 
Sera collected at a Finnish Veterinary meeting in 2001
showed that every person >50 years had orthopoxvirus
antibodies, as measured by IFA. The seroprevalence
decreased gradually for younger age groups (Table 3),
reflecting the gradual cessation of smallpox vaccination
(the last vaccinations in Finland occurred in 1977). The
average population might have lower seroprevalence rates
than veterinarians because of veterinarians’ frequent con-
tact with animals that may harbor orthopoxvirus.
Consequently, younger age groups are more susceptible to
smallpox and cowpox virus infections.
Although cowpox virus infection usually causes a sin-
gle, painful, ulcerated vesicopustule and local lym-
phadenopathy, immunocompromised patients and chil-
dren, especially those with atopic eczema, are susceptible
to a generalized, even lethal, smallpoxlike infection (5,6).
An early diagnosis and prompt recognition of the virus are
essential for treating and differentiating cowpox, from
other orthopoxvirus and herpesvirus infections, especially
in severe cases.
Conclusions
Cowpox virus (orthopoxvirus) infection was diagnosed
by electron microscopy, PCR, virus isolation, and serolog-
ic testing (positive IgM or low avidity of IgG antibodies).
Cowpox virus strains show considerable genetic variations
with different positioning in the orthopoxvirus phylogenet-
ic tree. Circulation of cowpox virus in wild and domestic
animals, together with decreased immunity in humans,
may lead to increased occurrence of human cowpox, espe-
cially in atopic and immunocompromised persons who are
at risk for generalized infection. The described case further
suggests atopy to be a contraindication to smallpox vacci-
nation.
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